Authors: Hes, FJ van der Luijt, RB Lips, CJM

Citation: Fj. Hes et al., Clinical management of Von Hippel-Lindau (VHL) disease, NETH J MED, 59(5), 2001, pp. 225-234

Authors: Hes, FJ Lips, CJM van der Luijt, RB

Citation: Fj. Hes et al., Molecular genetic aspects of Von Hippel-Lindau (VHL) disease and criteria for DNA analysis in subjects at risk, NETH J MED, 59(5), 2001, pp. 235-243

Authors: van der Luijt, RB van Zon, PHA Jansen, RPM van der Sijs-Bos, CJM Warlam-Rodenhuis, CC Ausems, MGEM

Citation: Rb. Van Der Luijt et al., De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer, J MED GENET, 38(2), 2001, pp. 102-105

Authors: Hes, FJ McKee, S Taphoorn, MJB Rehal, P van der Luijt, RB McMahon, R van der Smagt, JJ Dow, D Zewald, RA Whittaker, J Lips, CJM MacDonald, F Pearson, PL Maher, ER

Citation: Fj. Hes et al., Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only, J MED GENET, 37(12), 2000, pp. 939-943

Authors: Roijers, JFM de Wit, MJ van der Luijt, RB van Amstel, HKP Hoppener, JWM Lips, CJM

Citation: Jfm. Roijers et al., Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding, EUR J CL IN, 30(6), 2000, pp. 487-492